Literature DB >> 24156

Neural and endocrine development after chronic tryptophan deficiency in rats: I. Brain monoamine and pituitary responses.

P E Segall, H Ooka, K Rose, P S Timiras.   

Abstract

Caloric restriction and tryptophan deficient diets have been shown to delay aging in the immature laboratory rat. Studies of monoamine levels in the brain of developing female rats fed on these diets show changes in serotonin but not norepinephrine or dopamine levels: in tryptophan-restricted rats serotonin levels were reduced in all brain areas studied, whereas in caloric-restricted animals serotonin levels were increased in the cerebral hemispheres only. Another group of animals, in which growth and maturation was delayed by feeding d,1-parachlorophenylalanine (PCPA) showed decreases in serotonin, norepinephrine and dopamine concentrations in all brain regions investigated. All treatments employed to arrest growth and maturation resulted in pituitary alterations manifested by gross, histological and ultrastructural changes. It is postulated that there maturation- and age-retarding treatments delay the development of the central nervous system resulting in postponed maturation of the neuroendocrine axis, with consequent hypoactivity of certain pituitary functions and a resultant delay in the onset of maturation and senescence.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 24156     DOI: 10.1016/0047-6374(78)90048-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  2 in total

Review 1.  Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder.

Authors:  Valentina R Garbarino; T Lee Gilman; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-07-24       Impact factor: 7.658

Review 2.  Physiological and Molecular Mechanisms of Methionine Restriction.

Authors:  Mary Neslund Latimer; Khalid Walid Freij; Beth M Cleveland; Peggy R Biga
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-04       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.